World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
31418
World Ranking
16447
National Ranking
854

Dan Ziegler publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dan Ziegler sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 236 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dan Ziegler D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dan Ziegler sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dan Ziegler is affiliated with Heinrich Heine University Düsseldorf in Germany and focuses primarily on medicine, with a concentration in physiology, neurology, pharmacology, endocrinology, diabetes, metabolism, and molecular biology. Their research contributions revolve around key topics such as pain mechanisms and treatments, botulinum toxin and related neurological disorders, pharmacology and obesity treatment, Parkinson's disease mechanisms and treatments, neurological disorders and treatments, heart rate variability and autonomic control, and myofascial pain diagnosis and treatment.

The scientist has authored numerous papers with recent notable publications including:

  • Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations (2021), Diabetes Research and Clinical Practice
  • Current concepts in the management of diabetic polyneuropathy (2020), Journal of Diabetes Investigation

Other influential papers relevant to their domain but authored by others include "Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy" (2022) published in ADA Clinical Compendia and "Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy" (2022) appearing in Diabetologia.

Frequent collaborations have been established with researchers such as Michael Roden, Gidon J. Bönhof, Christian Herder, Wolfgang Rathmann, and Julia Szendroedi, reflecting a network of co-authors who have jointly contributed to the field over numerous publications.

Ziegler has regularly published in several key venues recognized within the domain of diabetes and metabolic research. These venues include:

  • Diabetologie und Stoffwechsel
  • Diabetologia
  • Diabetes Research and Clinical Practice
  • Die Diabetologie
  • Der Diabetologe

Their research largely addresses clinical and physiological aspects of diabetic neuropathies and related neurological complications, signifying an intersection between clinical practice and experimental investigations.

Best Publications

  • Diabetic neuropathies: a statement by the American Diabetes Association.

    Andrew J.M. Boulton;Andrew J.M. Boulton;Arthur I. Vinik;Joseph C. Arezzo;Vera Bril

  • Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    Rodica Pop-Busui;Andrew J.M. Boulton;Eva L. Feldman;Vera Bril

  • Diabetic Cardiovascular Autonomic Neuropathy

    Aaron I. Vinik;Dan Ziegler

  • Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

    Vincenza Spallone;Dan Ziegler;Roy Freeman;Luciano Bernardi

  • Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis

    D. Ziegler;H. Nowak;P. Kempler;P. Vargha

  • Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial

    Dan Ziegler;Alexander Ametov;Alexey Barinov;Peter J. Dyck

  • Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus.

    Miroslav Misha Backonja;Nadine Attal;Ralf Baron;Didier Bouhassira

  • Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy The MONICA/KORA Augsburg Surveys S2 and S3

    Dan Ziegler;Wolfgang Rathmann;Thorsten Dickhaus;Christa Meisinger

  • Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.

    D Ziegler;M Hanefeld;K J Ruhnau;H Hasche

  • Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

    Giuseppe Lauria;Mayienne Bakkers;Christoph Schmitz;Raffaella Lombardi

  • Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

    Angelika Bierhaus;Thomas Fleming;Stoyan Stoyanov;Andreas Leffler;Andreas Leffler

  • Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

    Dan Ziegler;Phillip A. Low;William J. Litchy;Andrew J.M. Boulton

  • Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.

    Dan Ziegler

  • Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate.

    Marcus W. Agelink;Rolf Malessa;Bruno Baumann;Thomas Majewski

  • The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

    Alexander S. Ametov;Alexei Barinov;Peter J. Dyck;Robert Hermann

  • α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany : Current evidence from clinical trials

    D. Ziegler;M. Reljanovic;H. Mehnert;F. A. Gries

  • Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.

    Oana P Zaharia;Klaus Strassburger;Alexander Strom;Gidon J Bönhof

  • Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.

    Dan Ziegler;G. Laux;K. Dannehl;M. Spüler

  • Mortality in diabetic patients with cardiovascular autonomic neuropathy.

    W. Rathmann;D. Ziegler;M. Jahnke;B. Haastert

  • The Epidemiology of Diabetic Neuropathy

    D Ziegler;F A Gries;M Spüler;F Lessmann

Frequent Co-Authors

Roy Freeman
Roy Freeman Beth Israel Deaconess Medical Center
Phillip A. Low
Phillip A. Low Mayo Clinic
Peter J. Dyck
Peter J. Dyck Mayo Clinic
Andrew J.M. Boulton
Andrew J.M. Boulton University of Manchester
Karl-Josef Langen
Karl-Josef Langen Forschungszentrum Jülich
David Yarnitsky
David Yarnitsky Technion – Israel Institute of Technology
Roman Rolke
Roman Rolke RWTH Aachen University
Smriti Iyengar
Smriti Iyengar Eli Lilly (United States)
Anne Louise Oaklander
Anne Louise Oaklander Harvard University
Eva L. Feldman
Eva L. Feldman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several related online degree options and career paths to explore. In addition to traditional medical school, pursuing a career in healthcare administration is increasingly popular. Affordable options like cheap mha programs allow students to develop leadership skills and prepare for healthcare management roles, all with flexible online study.

For those interested in advanced nursing opportunities, there are cheapest dnp online programs available, helping registered nurses earn their Doctor of Nursing Practice at a lower cost without interrupting their careers. Pharmacists can also advance with online pharmacist programs that offer affordable doctorate-level training.

If managing patient data or health systems interests you, you might explore rhia certification programs online. These degrees prepare students for certification and leadership jobs in health information management. Exploring these online options allows aspiring professionals to balance education, affordability, and flexible career advancement.

Best Scientists Citing Dan Ziegler

Trending Scientists